The standard of care for proliferative retinopathies, such as diabetic retinopathy and age-related macular degeneration, has long relied on invasive intravitreal injections. These direct-to-eye needle procedures are often painful and carry risks of infection or increased ocular pressure. However, a scientific breakthrough published in April 2026 by researchers at Wayne State University and Washin…
